News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Steep Decline in Cardiac Device Infections Reported with Use of the TYRX Antibacterial Envelope



3/26/2012 11:09:28 AM

CHICAGO--(BUSINESS WIRE)--Use of TYRX, Inc.’s AIGISRx® Antibacterial Envelope significantly reduced infection rates in patients undergoing pacemaker and implantable defibrillator implants, who were at high risk of surgical infections, according to a study presented today at the American College of Cardiology 61st Annual Scientific Session in Chicago, IL.

Read at BioSpace.com


comments powered by Disqus
TYRX
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES